For The 1st time, WHO’s treatment suggestions involve a clear recommendation for the usage of extended-performing injectable cabotegravir and rilpivirine (CAB/RPV) in its place switching selection for antiretroviral therapy (ART) for Older people and adolescents who've achieved whole viral suppression on oral ART and don't have Energetic hepatitis B an https://g.page/r/CfXqQhfboBkBEBM